Ładuje się......
Renovascular hypertension from the BCR‐ABL tyrosine kinase inhibitor ponatinib
Drug‐induced hypertension is one of the commonest causes of secondary hypertension. In the last few years, secondary hypertension due to tyrosine kinase inhibitors, from the vascular endothelial growth factor class, has been recognized to be an important cause of hypertension, as well as proteinuria...
Zapisane w:
| Wydane w: | J Clin Hypertens (Greenwich) |
|---|---|
| Główni autorzy: | , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley and Sons Inc.
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8029973/ https://ncbi.nlm.nih.gov/pubmed/32175644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13843 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|